Zeiss Group Opens New R&D and Manufacturing Site in China

By Staff
Monday, July 15, 2024 2:01 PM SUZHOU, China—The Zeiss Group announced the opening of its new R&D and manufacturing site on July 8, 2024, in Suzhou Industrial Park (SIP). Covering an area of more than 13,000 square meters, the new site marks the group's first land purchase for its self-built project in China.

Location Determines New Home Sales Prices, Census Bureau Report Says

By Staff
Monday, July 15, 2024 12:33 PM A home’s location has never been more important to its sales’ value, according to a new report from the U.S. Census Bureau. The report found that the price of new homes sold in 2023 varied by as much as $74 per square foot, depending on the area of the country. 

The average median price per square foot for a new home in the South was just over $146, while a home in the Midwest averaged $156.26. The Northeast saw the highest average price at $220.95 per square foot. The West averaged $195.38 per square foot. 

The organization noted that 660,000 single family homes were built in 2023, with an average median price of $428,000. These new homes had an average median size of nearly 2,300 square feet and a median price of $154.70 per square foot. 

The Northeast had the highest average median price for a home priced at $760,700 at a size of 2,430 square feet, followed by the West at $536,200, at 2,170 square feet. The average median price in the Midwest was $396,300 at 2,176 square feet, while the South saw an average home price of $388,800 at a size of 2,335 square feet, according to the Census Bureau.

Virtual Field and PECAA Expand Access to Virtual Visual Field Testing for Independent ECPs

By Staff
Monday, July 15, 2024 12:21 AM NEW YORK and BOCA RATON, Fla.—Virtual Field, a provider of virtual visual field testing technology, together with Professional Eye Care Associates of America (PECAA), a community of independent eyecare professionals, has announced a collaboration they said is aimed at increasing private practice access to in-practice eye exam technology.

Merck Completes Acquisition of EyeBio

By Staff
Monday, July 15, 2024 12:18 AM RAHWAY, N.J.—Merck, a research-intensive biopharmaceutical company known as MSD outside of the U.S. and Canada, has announced the completion of the acquisition of Eyebiotech Limited, a privately held ophthalmology-focused biotechnology company.

University of North Carolina at Pembroke Establishes School of Optometry, Names Dr. Rich Castillo as Founding Dean

By Staff
Monday, July 15, 2024 12:15 AM PEMBROKE, N.C.—During a special meeting held on July 9, the Board of Trustees named Dr. Rich Castillo the founding dean of the school of optometry at the University of North Carolina at Pembroke (UNCP).

read on Appoints Prolens AG as First European Distribution Partner

By Staff
Friday, July 12, 2024 3:11 PM ZURICH, Switzerland—read on, a Swiss reading glasses design company, has appointed Prolens AG as a new distribution partner for its "read on light" reading glasses in Switzerland and Austria, to advance market growth and expansion in Europe, the company announced.

Consumers Begin Back-to-School Shopping, NRF Survey Finds

By Staff
Friday, July 12, 2024 2:21 PM School shopping is well underway, according to a new report from the National Retail Federation (NRF) and Prosper Insights & Analytics. The annual Back to School survey finds that 55 percent of back-to-school and college shoppers have already begun buying items for the upcoming school year.

Despite the early start, more than 86 percent of consumers responded they still had at least half of their back-to-school purchases to complete. Approximately 45 percent of consumers said they were waiting for better deals to begin shopping, while 45 percent said they were unsure of what they needed for back-to-school supplies and had not begun yet. 

Online shopping remains one of the most popular ways to stock up on school supplies, with 85 percent of consumers saying they will take advantage of Prime Day and other retailer sales in July. 

Total back-to-school spending is predicted to reach nearly $39 billion, the second-highest figure on record, following last year's record-breaking $41.5 billion in back-to-school sales. 

Families with students in elementary school are expected to pay an average of $874.68 on clothing, shoes, school supplies and electronics, down $15 compared with 2023. 

Meanwhile, college students and their families are expected to spend an average of $1,364.75 on items for the upcoming school year, in line with last year’s record of $1,366, according to the NRF. College students are expected to spend an average of $359 on electronics, $192 on dorm or apartment furnishings, $171 on clothing and accessories, $149 on food and $112 on shoes. 

The NRF noted spending remains in line with last year, with 57 percent of consumers choosing to buy online, while 50 percent responded they will be shopping in department stores. Approximately 47 percent said they will be shopping in discount stores and 42 percent said they will be getting their back-to-school items from clothes stores.

NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million

By Staff
Friday, July 12, 2024 8:05 AM NovaBay Pharmaceuticals reports preliminary Q2 2024 net revenue; AAO and NANOS offer advice on weight loss drug and eye health risk; ECPs’ gross revenue decreased, Jobson Tracker says; Bausch + Lomb releases “State of Dry Eye” survey; and ECPs expect changes to workload, bottom line in response to Eyeglass Rule's final updates all topped this week’s VMAIL news feed. Click on the headlines below to catch up on anything you might have missed.

NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million

By Staff
Friday, July 12, 2024 12:24 AM EMERYVILLE, Calif.—NovaBay Pharmaceuticals, Inc. (NYSE American: NBY), a developer of eyecare, skin care and wound care products, has announced preliminary net revenue of $2.4 million for the second quarter of 2024 and $5.0 million for the first half of 2024, primarily derived from the company’s eyecare products. Net revenue from the company’s eyecare products increased by 9 percent for both the second quarter and the first half of 2024 compared with the corresponding periods in 2023, the company noted. NovaBay also said it expects 2024 net revenue from the company’s eyecare products to be approximately $10 million.

iOR Partners Appoints Lance J. Kugler, MD, as Strategic Advisory Board Chairman

By Staff
Friday, July 12, 2024 12:21 AM KANSAS CITY, Mo.—iOR Partners, a specialist in ophthalmic office-based surgery (OBS), announced that Lance J. Kugler, MD, has been named chairman of its strategic advisory board.

Clearside Biomedical Names Dr. Glenn Yiu to its Scientific Advisory Board

By Staff
Friday, July 12, 2024 12:18 AM ALPHARETTA, Ga.—Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company, has announced the appointment of Glenn C. Yiu, MD, PhD, professor of ophthalmology at the University of California, Davis, to its scientific advisory board.

read on Appoints Prolens AG as First European Distribution Partner

By Staff
Friday, July 12, 2024 12:15 AM ZURICH, Switzerland—read on, a Swiss reading glasses design company, has appointed Prolens AG as a new distribution partner for its "read on light" reading glasses in Switzerland and Austria, to advance market growth and expansion in Europe, the company announced.

Physical Activity Falls Globally, World Health Organization Report Finds

By Staff
Thursday, July 11, 2024 11:46 AM The World Health Organization (WHO) is sounding the alarm after new data revealed that one-third of the adults worldwide, or 1.8 billion people, did not meet recommended levels of physical activity in 2022. The WHO said the findings indicate a worrying trend of physical inactivity among adults, which they said, has increased 5 percentage points between 2010 and 2022. 

WHO warned that if these levels of inactivity continue to rise to a projected 35 percent by 2030, the world will remain off track from meeting the global target to reduce physical inactivity by 2030. 

The WHO recommends that adults have 150 minutes of moderate-intensity, or 75 minutes of vigorous-intensity physical activity, or its equivalent, per week. Adding physical activity to weekly schedules can reduce the risk of cardiovascular diseases such as heart attacks and strokes, type 2 diabetes, dementia and cancers.

The WHO reports many countries are making an effort to improve these results, with 22 countries identified as likely to reach the global target of reducing inactivity by 15 percent by 2030. Despite this trend, the WHO is calling on countries to strengthen their policy implementation to promote and enable physical activity through grassroots and community sports, active recreation and transport. 

“These new findings highlight a lost opportunity to reduce cancer and heart disease, and improve mental health and well-being through increased physical activity,” said Dr. Tedros Adhanom Ghebreyesus, director-general of the WHO. “We must renew our commitment to increasing levels of physical activity and prioritizing bold action, including strengthened policies and increased funding, to reverse this worrying trend.”

Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief

By Staff
Thursday, July 11, 2024 10:44 AM Bausch + Lomb Corporation shared results from the company’s inaugural State of Dry Eye survey, which explores dry eye understanding and experiences among American adults. Dry eye is increasingly common and can range from occasional symptoms of dryness to a chronic condition called dry eye disease.

American Academy of Ophthalmology and North American Neuro-Ophthalmology Society Offer Advice on Weight Loss Drug and Eye Health Risk

By Staff
Thursday, July 11, 2024 12:24 AM SAN FRANCISCO—The American Academy of Ophthalmology and the North American Neuro-Ophthalmology Society have issued a response to a recent study that suggests patients taking semaglutide—the active ingredient in Ozempic and Wegovy—may be at higher risk of developing non-arteritic anterior ischemic optic neuropathy, or NAION, an eye condition that can cause blindness. The study, conducted by researchers at Harvard University, was published on July 3, 2024 in JAMA Ophthalmology. “Because diabetes is a known risk factor for NAION, patients with diabetes who qualify for GLP-1 treatment may be at higher risk for NAION to begin with," Andrew Lee, MD, clinical spokesperson for the American Academy of Ophthalmology and a neuro-ophthalmologist at Houston Methodist Hospital, told VM.